| Abstrak/Abstract |
One of the purposes of stroke therapy is to prevent recurrent stroke using secondary prevention by administering antiplatelet/anticoagulant, antihypertensive, anti-dyslipidemia, and antihyperglycemic. This study aimed to find the influence of secondary prevention on the occurrence of recurrent stroke and determine the factors involved in the event of recurrent stroke. This research was conducted with a quantitative approach and a retrospective case-control study. The subjects were 165 respondents consisting of 82 respondents in the case group and 83 respondents in the control group. Data were analyzed using bivariate/chi-square and logistic regression multivariate tests. The result showed that secondary prevention and patient compliance reduced the incidence of recurrent stroke. The rate of recurrent stroke was decreased from 68% to 24% by antiplatelet therapy and compliance, from 69% to 23% by antihypertensive and compliance, from 54% to 29% by antilipidemic and compliance, from 52% to 23% by antihyperglycemic and compliance, and the combination of these four secondary preventions reduced the recurrent stroke from 52% to 13%. Multivariate analysis showed that the several factors involved in determining the rate of recurrent stroke, namely patients who did not use antihypertensive therapy (P=0,000; OR 9.871), had systolic blood pressure≥140mmHg (P=0,011; OR 3,156), HDL<40mg/dl (P=0,005; OR 3,594), and the lack of exercise (P=0,048; OR 2,365) |
